Business Description
Aptamer Sciences Inc
ISIN : KR7291650000
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.87 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.54 | |||||
Debt-to-EBITDA | -0.71 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.82 | |||||
Beneish M-Score | -3.62 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.9 | |||||
3-Year EBITDA Growth Rate | -43.6 | |||||
3-Year EPS without NRI Growth Rate | -41.8 | |||||
3-Year FCF Growth Rate | -39.4 | |||||
3-Year Book Growth Rate | -24.6 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 31.28 | |||||
9-Day RSI | 30.39 | |||||
14-Day RSI | 32.58 | |||||
6-1 Month Momentum % | -5.85 | |||||
12-1 Month Momentum % | -13.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.64 | |||||
Quick Ratio | 1.64 | |||||
Cash Ratio | 1.56 | |||||
Days Inventory | 411.45 | |||||
Days Sales Outstanding | 22.65 | |||||
Days Payable | 56.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -13.32 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 78.57 | |||||
Operating Margin % | -5019.45 | |||||
Net Margin % | -5593.02 | |||||
FCF Margin % | -4743.78 | |||||
ROE % | -61.32 | |||||
ROA % | -34.93 | |||||
ROIC % | -108.58 | |||||
ROC (Joel Greenblatt) % | -157.88 | |||||
ROCE % | -35.58 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 183.3 | |||||
PB Ratio | 2.96 | |||||
Price-to-Tangible-Book | 2.98 | |||||
EV-to-EBIT | -2.42 | |||||
EV-to-EBITDA | -2.53 | |||||
EV-to-Revenue | 121.42 | |||||
EV-to-FCF | -2.57 | |||||
Price-to-Net-Current-Asset-Value | 5.93 | |||||
Price-to-Net-Cash | 6.62 | |||||
Earnings Yield (Greenblatt) % | -41.26 | |||||
FCF Yield % | -25.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aptamer Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 243.187 | ||
EPS (TTM) (â‚©) | -801 | ||
Beta | 0.01 | ||
Volatility % | 35.82 | ||
14-Day RSI | 32.58 | ||
14-Day ATR (â‚©) | 166.051812 | ||
20-Day SMA (â‚©) | 2968.75 | ||
12-1 Month Momentum % | -13.84 | ||
52-Week Range (â‚©) | 2400 - 6080 | ||
Shares Outstanding (Mil) | 16.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aptamer Sciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aptamer Sciences Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Aptamer Sciences Inc Frequently Asked Questions
What is Aptamer Sciences Inc(XKRX:291650)'s stock price today?
When is next earnings date of Aptamer Sciences Inc(XKRX:291650)?
Does Aptamer Sciences Inc(XKRX:291650) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |